University of Mississippi researchers have discovered how a compound found in cannabis might be used to mitigate the negative ...

SOUTH SAN FRANCISCO, Calif. - Vistagen Therapeutics (VTGN), a clinical-stage biopharmaceutical company with a market ...

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Using an innovative and recently validated animal model of IBS, the researchers showed that opioid delta-receptor agonists can ameliorate stress-induced IBS symptoms by acting on the insular cortex of ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

A study on rats found that administering 2,5-dimethoxy-4-iodoamphetamine before giving them an opportunity to take heroin ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

US President Donald Trump yesterday ordered 25% tariffs on Canadian and Mexican imports – lumping a 10% tax rate on goods from China as well saying Beijing needed to stanch the flow of fentanyl, a ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

With drug-overdose deaths in Nebraska more than doubling in a few years, having Narcan and knowing how to use it can be a ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...